FI67847C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner Download PDF

Info

Publication number
FI67847C
FI67847C FI792848A FI792848A FI67847C FI 67847 C FI67847 C FI 67847C FI 792848 A FI792848 A FI 792848A FI 792848 A FI792848 A FI 792848A FI 67847 C FI67847 C FI 67847C
Authority
FI
Finland
Prior art keywords
erythro
hydroxy
acid
nonyl
pacba
Prior art date
Application number
FI792848A
Other languages
English (en)
Finnish (fi)
Other versions
FI792848A (fi
FI67847B (fi
Inventor
Alfredo Giner-Sorolla
Original Assignee
Sloan Kettering Inst Cancer
Newport Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer, Newport Pharmaceuticals filed Critical Sloan Kettering Inst Cancer
Publication of FI792848A publication Critical patent/FI792848A/fi
Application granted granted Critical
Publication of FI67847B publication Critical patent/FI67847B/fi
Publication of FI67847C publication Critical patent/FI67847C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Adhesives Or Adhesive Processes (AREA)
FI792848A 1978-09-15 1979-09-13 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner FI67847C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94280478 1978-09-15
US05/942,804 US4221910A (en) 1978-09-15 1978-09-15 9-(Hydroxy alkyl)purines

Publications (3)

Publication Number Publication Date
FI792848A FI792848A (fi) 1980-03-16
FI67847B FI67847B (fi) 1985-02-28
FI67847C true FI67847C (fi) 1985-06-10

Family

ID=25478624

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792848A FI67847C (fi) 1978-09-15 1979-09-13 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner

Country Status (26)

Country Link
US (1) US4221910A (ko)
EP (1) EP0009155B1 (ko)
JP (1) JPS5559188A (ko)
AT (1) ATE1814T1 (ko)
AU (1) AU527881B2 (ko)
CA (1) CA1121818A (ko)
CS (1) CS241023B2 (ko)
DD (1) DD146050A5 (ko)
DE (1) DE2964059D1 (ko)
DK (1) DK145627C (ko)
ES (1) ES484168A1 (ko)
FI (1) FI67847C (ko)
GR (1) GR72523B (ko)
HU (1) HU180892B (ko)
IE (1) IE48826B1 (ko)
IL (1) IL58086A (ko)
IN (1) IN153050B (ko)
MX (1) MX6270E (ko)
NO (1) NO152446C (ko)
NZ (1) NZ191482A (ko)
PH (1) PH15921A (ko)
PL (2) PL124177B1 (ko)
PT (1) PT70179A (ko)
RO (1) RO77559A (ko)
YU (1) YU41885B (ko)
ZA (1) ZA793972B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
JPS59135334A (ja) * 1983-01-24 1984-08-03 Kawasaki Steel Corp デジタル式張力測定装置
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
AU709454B2 (en) * 1994-07-25 1999-08-26 Alvin J. Glasky Carbon monoxide dependent guanylyl cyclase modifiers
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH443312A (fr) * 1963-10-29 1967-09-15 Ajinomoto Kk Procédé de préparation du 1-N-oxyde d'hypoxanthine et du 1-N-oxyde d'inosine substituée ou non, et utilisation des produits obtenus par ce procédé poutilisation des produits obtenus par ce procédé pour la préparation de la 2,6-dichloro-purine et 9-B-D-ribofuranosyl purine substitua ée ou non
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3813394A (en) * 1969-08-18 1974-05-28 Fujisawa Pharmaceutical Co Purine derivatives having hypocholesterolemic activity
JPS504012A (ko) * 1972-12-16 1975-01-16
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant

Also Published As

Publication number Publication date
IE48826B1 (en) 1985-05-29
FI792848A (fi) 1980-03-16
US4221910A (en) 1980-09-09
DK145627C (da) 1983-06-20
AU5055679A (en) 1980-03-20
IN153050B (ko) 1984-05-26
CA1121818A (en) 1982-04-13
DE2964059D1 (en) 1982-12-23
PH15921A (en) 1983-04-22
CS241023B2 (en) 1986-03-13
RO77559A (ro) 1982-02-01
JPS5559188A (en) 1980-05-02
PL124177B1 (en) 1982-12-31
EP0009155B1 (en) 1982-11-17
HU180892B (en) 1983-05-30
NZ191482A (en) 1984-04-27
YU224679A (en) 1984-06-30
MX6270E (es) 1985-02-27
JPH031310B2 (ko) 1991-01-10
NO152446C (no) 1985-10-02
DK145627B (da) 1983-01-03
ATE1814T1 (de) 1982-12-15
PL124228B1 (en) 1983-01-31
ZA793972B (en) 1980-09-24
IL58086A (en) 1982-04-30
AU527881B2 (en) 1983-03-31
ES484168A1 (es) 1980-09-01
NO152446B (no) 1985-06-24
FI67847B (fi) 1985-02-28
GR72523B (ko) 1984-11-16
YU41885B (en) 1988-02-29
IE791752L (en) 1980-03-15
PL218318A1 (ko) 1980-06-16
CS622779A2 (en) 1985-06-13
IL58086A0 (en) 1979-12-30
NO792791L (no) 1980-03-18
DD146050A5 (de) 1981-01-21
PT70179A (en) 1979-10-01
DK385579A (da) 1980-03-16
EP0009155A1 (en) 1980-04-02

Similar Documents

Publication Publication Date Title
FI67847B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner
AU683270B2 (en) Novel chemical compounds having PDE-IV inhibition activity
CS203092B2 (en) Method of preparing substituted purines
EP0009154B1 (en) Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients
SI9010633A (en) Process for preparing pteridine-4(3h)-ones and medicaments containing them
EP0308897A1 (en) Quinoline derivatives
CA2367143A1 (en) Purine derivatives having phosphodiesterase iv inhibition activity
CA2583437C (en) Novel inhibitors of folic acid-dependent enzymes
EP0186454B1 (en) 6-purinyl n-(2-chloroethyl) carbamate and thiocarbamate, a process for their preparation and use thereof
KR830000709B1 (ko) 9-(하이드록시알킬) 푸린류의 제조방법
CA2226980A1 (en) Purine and guanine derivatives
JPH06239841A (ja) ６，７−ジヒドロ−５Ｈ−シクロペンタ〔ｄ〕ピリミジン誘導体
JP2694990B2 (ja) 気管支拡張剤としてのトリアゾロ〔１，５―ｃ〕ピリミド〔１，４〕アジン類
Schaeffer et al. Enzyme inhibitors XVI. Mode of binding of some 9‐(2‐hydroxyalkyl)‐6‐(substituted)‐purines to adenosine deaminase
MXPA01010001A (en) Purine derivatives having phosphodiesterase iv inhibition activity
JPH04270281A (ja) ２′，３′−ジデオキシ−６−（メチル）セレノプリンヌクレオシド誘導体、その製法及びそれを利用した抗ウイルス剤
NZ199643A (en) Treatment with immunomodulators and antiviral agents which are 9-(2-hydroxyalkyl) purine amine salt complexes

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: NEWPORT PHARMACEUTICALS INTERNATIONAL, INC.

Owner name: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH